The TIKR Blog
Sharing actionable investing insights, in-depth stock analysis, and expert tips to help you make smarter investment decisions and think like a business owner.
Latest Posts
Discover our most recent fundamental investing insights.

Elevance Health (ELV) Stock: Analysts See 30% Upside for This Dividend Growth Stock
Elevance Health (ELV) looks undervalued today, with analysts seeing up to 30% upside. The company continues to raise its dividend while delivering strong earnings and steady growth in its Blue Cross and Blue Shield plans.

10 Stocks with Explosive Earnings Growth Ahead
Here are 10 stocks with explosive earnings growth expected in the years ahead. Analysts think these stocks could see sharp increases in profits and long-term upside.

GE Vernova Stock Trades at a Premium In 2025. Is GEV Stock Still a Good Buy?
The 2-Minute Valuation Model values GEV stock at $560/share in 2 years. That’s a potential 31% upside from today’s price of $427/share.

Lam Research (LRCX) Stock: 11% Annual Dividend Growth for This Chip Stock
Lam Research combines consistent double-digit dividend growth with exposure to long-term semiconductor demand. Analysts expect strong EPS and dividend growth through 2028, which could make LRCX a compelling pick for dividend-focused tech investors.

Here’s Why Uber Stock Could Surge 33% Over the Next 2 Years
The 2-Minute Valuation Model values Uber stock at $120/share in 2 years. That’s a potential 33% upside from today’s price of $90/share.

10 Undervalued Small-Caps That Insiders Are Buying
In this article, we’re covering 10 undervalued small-cap stocks that insiders have been buying recently and why they could be worth a closer look.

Why Coinbase (COIN) Stock Fell 7% Yesterday
Coinbase (COIN) stock fell 7% yesterday after the crypto exchange stated hackers bribed staff to steal customer data.

3 Reasons GitLab (GTLB) Stock Looks Like a Strong Buy Right Now
GitLab is a growth stock trading at a premium valuation in 2025. But here’s why you should consider owning GTLB stock today.

UnitedHealth (UNH) Stock Tanks 11% On Possible Medicare Fraud
UnitedHealth (UNH) stock has been in a downward spiral in 2025 as the healthcare giant continues to wrestle with regulatory and company-specific headwinds.

Can Monday.com (MNDY) Stock Continue to Beat the S&P 500 In the Next Two Years?
The 2-Minute Valuation Model values MNDY stock at $350/share in 2 years. That’s a potential 21% upside from today’s price of $290/share.

Why Dutch Bros Stock Might Underperform Over the Next 2 Years
The 2-Minute Valuation Model values Dutch Bros stock at $80/share in 2 years. That’s a potential 11% upside from today’s price of $72/share.
Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.